(Q51728271)

10 April 2018

title

Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study. (English)

1 reference

10 April 2018

1 reference

Cupressus arizonica

1 reference

Cupressaceae

1 reference

Ariano R

1

1 reference

10 April 2018

Spadolini I

series ordinal

2

1 reference

10 April 2018

Panzani RC

series ordinal

3

1 reference

10 April 2018

publication date

1 November 2001

1 reference

10 April 2018

Allergologia et Immunopathologia

published in

1 reference

10 April 2018

volume

29

1 reference

10 April 2018

issue

6

1 reference

10 April 2018

page(s)

238-244

1 reference

10 April 2018

Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Cupressaceae pollinosis in the Madrid area

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

REPOSITORY EMULSION THERAPY FOR MOUNTAIN CEDAR POLLINOSIS: A DOUBLE-BLIND STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Immunotherapy for mountain cedar pollinosis. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Suppression of the late cutaneous response by immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

The relationships between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

Diagnosis of allergy by an in-vitro test for allergen antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979065-9

7 January 2021

10.1016/S0301-0546(01)79065-9

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018